Diagnostic work with suspected cases of systemic meningococcal disease in the Norwegian serogroup B vaccine protection trials.
Holten
E
E
Department of Microbiology, Akershus Central Hospital, Nordbyhagen.
Bruun
J N
JN
Hellum
K B
KB
Maeland
J A
JA
D016667:Bacterial Capsules; D001425:Bacterial Outer Membrane Proteins / Q000276:immunology; D001428:Bacterial Vaccines / Q000009:adverse effects / Q000276:immunology; D002985:Clinical Protocols / Q000592:standards*; D002986:Clinical Trials as Topic; D006801:Humans; D008589:Meningococcal Infections / Q000145:classification / Q000453:epidemiology / Q000382:microbiology*; D022401:Meningococcal Vaccines; D009664:Norway / Q000453:epidemiology; D011135:Polysaccharides, Bacterial / Q000276:immunology; D011159:Population Surveillance / Q000379:methods*; D011379:Prognosis; D012703:Serotyping; D012720:Severity of Illness Index
D001425:Bacterial Outer Membrane Proteins; D001428:Bacterial Vaccines; D022401:Meningococcal Vaccines; D011135:Polysaccharides, Bacterial; C039455:capsular polysaccharide, meningococcal group B